Member Info for Doggy100

To wet for that iPad

And it’s solid granite about 2 foot underneath for me to plough!!

I’m do some sheep rustling to get my money back!!

Why would you appoint Simon bennet on £300k if it’s not going all to plan?

Sensible answers as I don’t understand it !

I tried on Friday night

I had 11 pints of guiness and a bottle of red wine typed utter garbage

I pi22ed in the wardrobe at 3am mrs fuming and I’m still here it’s just ridiculous

🤪🤪🤪

I think he’s probably been shorting all the way 🤪🤪

Still posting on twitter

He’s got some neck 😂

I’ve just unfiltered wyndrum to see what he’s saying on the he1 board

What a dodgy character

Filter him you will feel better

As my very good friend who works for a big company in the city said to me last summer,

Stay away from those bullletin boards stay well away !

Hence I rarely post now

All the best

See you all next week

Imagine how amateurish it would look if they had to issue an rns to its lowlife pathetic shareholders to tell them everything is ok and we’ve fixed the problem!

Far to busy shrinking tumours and extending peoples lives than typing up rns’s to silly immature investors who genuinely have no idea what they are doing and should stay well clear of investing especially investing in a company like Avacta !

Thank god they’ve brought out the new tenor men for men who dribble in their pants

Coz I’m absolutely wetting myself

The avacta board had agreed to pay a man £300k a year.

A man of monumental power and experience in licensing deals all over planet Earth and people think it’s a goner 🤪🤪🤪🤪

This will climb like a monkey in a forest fire when the deal lands …make no mistake!!

Note: no monkeys were hurt in this experiment

80 commercial deals🤪🤪🤪

And people think it’s over 🤪🤪🤪🤪🤪😂😂😂😂🤪🤪🤪

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics, is pleased to announce the appointment of Dr Simon Bennett as Chief Business Officer of the Therapeutics Division.

Simon has over 26 years' commercial experience in the biopharma industry. He has worked with companies from large and mid-sized pharma such as Bristol-Myers-Squibb and Menarini Group to early stage biotechs, supporting business development and licensing activities in addition to being involved in all aspects of business and corporate development. Simon has been involved in over 80 commercial deals across Europe, North America, Australasia, Japan, Russia/CIS and South America.

I also could not care less if it went to 20p

Ive only invested what I can afford to lose.

That means if I’ve lost everything it doesn’t matter

Unlike some on here me thinks

I think I’m gonna sell all my shares

Shrinking cancerous tumours (fact) is not what I was expecting 😉

Dyor touk

If ava6000 works like we hope this really will be massive

My first post is a real good read if anyone can be bothered

Only 4 from England

https://www.fda.gov/media/110742/download

Https://www.fda.gov/about-fda/2023-oce-annual-report/ongoing-clinical-oncology-projects

Filtered wyn 2 years ago

He doesn’t bother me